Difference between revisions of "LncRNAWiki:B"
(4 intermediate revisions by 2 users not shown) | |||
Line 1: | Line 1: | ||
+ | |||
+ | <div style="padding:0.2em 0.5em;text-align:right;font-size:125%;font-weight:bold;color:#2d2d2d;"> | ||
+ | Jump to section in alphabetical order : [[LncRNAWiki:A|'''A''']] '''B''' [[LncRNAWiki:C|'''C''']] [[LncRNAWiki:D|'''D''']] [[LncRNAWiki:E|'''E''']] [[LncRNAWiki:F|'''F''']] [[LncRNAWiki:G|'''G''']] [[LncRNAWiki:H|'''H''']] [[LncRNAWiki:I|'''I''']] [[LncRNAWiki:J|'''J''']] [[LncRNAWiki:K|'''K''']] [[LncRNAWiki:L|'''L''']] [[LncRNAWiki:M|'''M''']] [[LncRNAWiki:N|'''N''']] [[LncRNAWiki:O|'''O''']] [[LncRNAWiki:P|'''P''']] [[LncRNAWiki:R|'''R''']] [[LncRNAWiki:S|'''S''']] [[LncRNAWiki:T|'''T''']] [[LncRNAWiki:U|'''U''']] [[LncRNAWiki:V|'''V''']] [[LncRNAWiki:W|'''W''']] [[LncRNAWiki:X|'''X''']] [[LncRNAWiki:Y|'''Y''']] [[LncRNAWiki:Z|'''Z''']] [[LncRNAWiki:Featured|'''BACK''']] | ||
+ | </div> | ||
{|class="wikitable sortable" style="width:90%;text-align:center" | {|class="wikitable sortable" style="width:90%;text-align:center" | ||
|- | |- | ||
Line 5: | Line 9: | ||
!Alias | !Alias | ||
!Description | !Description | ||
+ | !Disease | ||
|- | |- | ||
|''B3GALT5-AS1'' | |''B3GALT5-AS1'' | ||
Line 10: | Line 15: | ||
|N/A | |N/A | ||
|B3GALT5 antisense RNA 1 | |B3GALT5 antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''B4GALT1-AS1'' | |''B4GALT1-AS1'' | ||
Line 15: | Line 21: | ||
|N/A | |N/A | ||
|B4GALT1 antisense RNA 1 | |B4GALT1 antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''BAALC-AS2'' | |''BAALC-AS2'' | ||
Line 20: | Line 27: | ||
|MGC39526 | |MGC39526 | ||
|BAALC antisense RNA 2 | |BAALC antisense RNA 2 | ||
+ | |_ | ||
|- | |- | ||
|''BACE1-AS'' | |''BACE1-AS'' | ||
− | |[[NONHSAT024403]],[[lnc-RNF214-1:2]] | + | |[[NONHSAT024403]], |
− | |BACE1AS,NCRNA00177; FJ573250 | + | [[lnc-RNF214-1:2]] |
+ | |"BACE1AS,NCRNA00177; FJ573250" | ||
|BACE1 antisense RNA | |BACE1 antisense RNA | ||
+ | |Alzheimer's disease, | ||
|- | |- | ||
|''BANCR'' | |''BANCR'' | ||
Line 30: | Line 40: | ||
|LINC00586 | |LINC00586 | ||
|BRAF-activated non-protein coding RNA | |BRAF-activated non-protein coding RNA | ||
+ | |osteosarcoma, hepatocellular carcinoma, gastric cancer | ||
|- | |- | ||
|''BCAR4'' | |''BCAR4'' | ||
Line 35: | Line 46: | ||
|N/A | |N/A | ||
|breast cancer anti-estrogen resistance 4 (non-protein coding) | |breast cancer anti-estrogen resistance 4 (non-protein coding) | ||
+ | |breast cancer | ||
|- | |- | ||
|''BCYRN1'' | |''BCYRN1'' | ||
|[[lnc-EPCAM-1:2]] | |[[lnc-EPCAM-1:2]] | ||
− | |BC200,BC200a, NCRNA00004, LINC00004 | + | |"BC200,BC200a, NCRNA00004, LINC00004" |
− | |BCYRN1, brain cytoplasmic RNA 1 | + | |"BCYRN1, brain cytoplasmic RNA 1" |
+ | |Alzheimer's disease,breast cancer,cervical cancer, lung cancer,oesophagus cancer, ovarian cancer, parotid cancer,tongue cancer | ||
|- | |- | ||
|''BDNF-AS'' | |''BDNF-AS'' | ||
|[[ENST00000499008.3]] | |[[ENST00000499008.3]] | ||
|BDNF antisense RNA | |BDNF antisense RNA | ||
− | |BT2A, BT2B,BT2C,BT2D,NCRNA00049,BDNF-AS1, NCRNA00049 | + | |"BT2A, BT2B,BT2C,BT2D,NCRNA00049,BDNF-AS1, NCRNA00049" |
+ | |Huntington's disease, psychiatric disease, schizophrenia, obesity | ||
|- | |- | ||
|''Beta-globin transcripts'' | |''Beta-globin transcripts'' | ||
− | |[[NONHSAT017676]],[[NONHSAT017675]],[[NONHSAT017674]] | + | |[[NONHSAT017676]], |
+ | [[NONHSAT017675]], | ||
+ | [[NONHSAT017674]] | ||
|N/A | |N/A | ||
|N/A | |N/A | ||
+ | |_ | ||
|- | |- | ||
|''BFSP2-AS1'' | |''BFSP2-AS1'' | ||
Line 55: | Line 72: | ||
|MGC2848 | |MGC2848 | ||
|BFSP2 antisense RNA 1 | |BFSP2 antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''BGLT3'' | |''BGLT3'' | ||
|[[BGLT3]] | |[[BGLT3]] | ||
− | |LINC01083, BGL3, lncRNA-BGL3 | + | |"LINC01083, BGL3, lncRNA-BGL3" |
|beta globin locus transcript 3 (non-protein coding) | |beta globin locus transcript 3 (non-protein coding) | ||
+ | |Bcr-Abl-positive leukemia | ||
|- | |- | ||
|''BIN3-IT1'' | |''BIN3-IT1'' | ||
Line 65: | Line 84: | ||
|FLJ14107 | |FLJ14107 | ||
|BIN3 intronic transcript 1 | |BIN3 intronic transcript 1 | ||
+ | |_ | ||
|- | |- | ||
|''BIRC6-AS1'' | |''BIRC6-AS1'' | ||
Line 70: | Line 90: | ||
|N/A | |N/A | ||
|BIRC6 antisense RNA 1 | |BIRC6 antisense RNA 1 | ||
+ | |_ | ||
|- | |- | ||
|''BIRC6-AS2'' | |''BIRC6-AS2'' | ||
Line 75: | Line 96: | ||
|megamind | |megamind | ||
|BIRC6 antisense RNA 2 | |BIRC6 antisense RNA 2 | ||
+ | |_ | ||
|- | |- | ||
|''BISPR'' | |''BISPR'' | ||
Line 80: | Line 102: | ||
|N/A | |N/A | ||
|BST2 interferon stimulated positive regulator (non-protein coding) | |BST2 interferon stimulated positive regulator (non-protein coding) | ||
+ | |_ | ||
|- | |- | ||
|''BLACAT1'' | |''BLACAT1'' | ||
|[[BLACAT1]] | |[[BLACAT1]] | ||
− | |linc-UBC1,LINC00912, onco-lncRNA-30 | + | |"linc-UBC1,LINC00912, onco-lncRNA-30" |
|bladder cancer associated transcript 1 (non-protein coding) | |bladder cancer associated transcript 1 (non-protein coding) | ||
+ | |bladder cancer | ||
|- | |- | ||
|''BOK-AS1'' | |''BOK-AS1'' | ||
|[[BOK-AS1]] | |[[BOK-AS1]] | ||
− | |NCRNA00151, NAToB | + | |"NCRNA00151, NAToB" |
|BOK antisense RNA 1 | |BOK antisense RNA 1 | ||
+ | |testicular cancer | ||
|- | |- | ||
|''BPESC1'' | |''BPESC1'' | ||
|[[ENST00000418282.1]] | |[[ENST00000418282.1]] | ||
|NCRNA00187 | |NCRNA00187 | ||
− | |blepharophimosis, epicanthus inversus and ptosis, candidate 1 (non-protein coding) | + | |"blepharophimosis, epicanthus inversus and ptosis, candidate 1 (non-protein coding)" |
+ | |blepharophimosis syndrome | ||
|- | |- | ||
|''BRWD1-AS2'' | |''BRWD1-AS2'' | ||
Line 100: | Line 126: | ||
|N/A | |N/A | ||
|BRWD1 antisense RNA 2 | |BRWD1 antisense RNA 2 | ||
+ | |_ | ||
+ | |- | ||
+ | |''BTG3-AS1'' | ||
+ | |[[BTG3-AS1]] | ||
+ | |ASBEL | ||
+ | |BTG3 antisense RNA 1 | ||
+ | |Ovarian carcinoma | ||
+ | |- | ||
+ | |''BRE-AS1'' | ||
+ | |[[BRE-AS1]] | ||
+ | |N/A | ||
+ | |BRE antisense RNA 1 | ||
+ | |_ | ||
|} | |} |
Latest revision as of 12:34, 29 June 2017
Name | Transcript ID | Alias | Description | Disease |
---|---|---|---|---|
B3GALT5-AS1 | B3GALT5-AS1 | N/A | B3GALT5 antisense RNA 1 | _ |
B4GALT1-AS1 | B4GALT1-AS1 | N/A | B4GALT1 antisense RNA 1 | _ |
BAALC-AS2 | BAALC-AS2 | MGC39526 | BAALC antisense RNA 2 | _ |
BACE1-AS | NONHSAT024403, | "BACE1AS,NCRNA00177; FJ573250" | BACE1 antisense RNA | Alzheimer's disease, |
BANCR | BANCR | LINC00586 | BRAF-activated non-protein coding RNA | osteosarcoma, hepatocellular carcinoma, gastric cancer |
BCAR4 | BCAR4 | N/A | breast cancer anti-estrogen resistance 4 (non-protein coding) | breast cancer |
BCYRN1 | lnc-EPCAM-1:2 | "BC200,BC200a, NCRNA00004, LINC00004" | "BCYRN1, brain cytoplasmic RNA 1" | Alzheimer's disease,breast cancer,cervical cancer, lung cancer,oesophagus cancer, ovarian cancer, parotid cancer,tongue cancer |
BDNF-AS | ENST00000499008.3 | BDNF antisense RNA | "BT2A, BT2B,BT2C,BT2D,NCRNA00049,BDNF-AS1, NCRNA00049" | Huntington's disease, psychiatric disease, schizophrenia, obesity |
Beta-globin transcripts | NONHSAT017676, | N/A | N/A | _ |
BFSP2-AS1 | BFSP2-AS1 | MGC2848 | BFSP2 antisense RNA 1 | _ |
BGLT3 | BGLT3 | "LINC01083, BGL3, lncRNA-BGL3" | beta globin locus transcript 3 (non-protein coding) | Bcr-Abl-positive leukemia |
BIN3-IT1 | BIN3-IT1 | FLJ14107 | BIN3 intronic transcript 1 | _ |
BIRC6-AS1 | BIRC6-AS1 | N/A | BIRC6 antisense RNA 1 | _ |
BIRC6-AS2 | BIRC6-AS2 | megamind | BIRC6 antisense RNA 2 | _ |
BISPR | BISPR | N/A | BST2 interferon stimulated positive regulator (non-protein coding) | _ |
BLACAT1 | BLACAT1 | "linc-UBC1,LINC00912, onco-lncRNA-30" | bladder cancer associated transcript 1 (non-protein coding) | bladder cancer |
BOK-AS1 | BOK-AS1 | "NCRNA00151, NAToB" | BOK antisense RNA 1 | testicular cancer |
BPESC1 | ENST00000418282.1 | NCRNA00187 | "blepharophimosis, epicanthus inversus and ptosis, candidate 1 (non-protein coding)" | blepharophimosis syndrome |
BRWD1-AS2 | BRWD1-AS2 | N/A | BRWD1 antisense RNA 2 | _ |
BTG3-AS1 | BTG3-AS1 | ASBEL | BTG3 antisense RNA 1 | Ovarian carcinoma |
BRE-AS1 | BRE-AS1 | N/A | BRE antisense RNA 1 | _ |